New NHS treatment could transform lives of thousands of sick children
by Jane Kirby
Apr 24, 2024
3 minutes
A new treatment which could transform the lives of children with brain tumours has been approved on the NHS.
The combination of dabrafenib and trametinib can now be used for patients aged one and over with either low-grade or high-grade glioma with the genetic mutation BRAF V600E.
The new drug therapy has been approved by the National Institute for Health and Care Excellence (Nice) after studies showed it lessened chemotherapy side-effects, improved children’s response rate
You’re reading a preview, subscribe to read more.
Start your free 30 days